Shilpa Medicare Ltd (SHILPAMED) – Company Profile and SWOT Analysis

Shilpa Medicare Ltd (SHILPAMED) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Shilpa Medicare Ltd (Shilpa Medicare) develops, manufactures, and markets a broad range of generic pharmaceutical products, including active pharmaceutical ingredients (APIs), formulations, new drug delivery systems, peptides, specialty chemicals, and intermediates. The company offers oncology and non-oncology APIs and produces high-quality oral solids, liquid injections, and lyophilized injectables. It operates production facilities across India specializing in complex APIs, formulations, biologicals, and novel drug-delivery systems. Shilpa Medicare is also advancing its biologicals and biosimilars portfolio, including monoclonal antibodies, microbial biosimilars, vaccines, and recombinant human albumin. The company also provides contract research and manufacturing services (CDMO) for global clients. Shilpa Medicare is headquartered in Raichur, Karnataka, India.

Scope

• Detailed information on Shilpa Medicare Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Shilpa Medicare Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Shilpa Medicare Ltd including a breakdown and examination of key business segments

• News about Shilpa Medicare Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Shilpa Medicare Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Shilpa Medicare Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Shilpa Medicare Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Glenmark Pharmaceuticals Ltd

Lupin Ltd

J B Chemicals and Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Ltd

Natco Pharma Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Shilpa Medicare Ltd - Key Facts

Shilpa Medicare Ltd - Key Employees

Shilpa Medicare Ltd - Key Employee Biographies

Shilpa Medicare Ltd - Major Products and Services

Shilpa Medicare Ltd - History

Shilpa Medicare Ltd - Company Statement

Shilpa Medicare Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Affiliate

Joint Venture

Section 2 – Company Analysis

Company Overview

Shilpa Medicare Ltd - Business Description

Business Segment: Others

Performance

Business Segment: Pharmaceutical Products and Services

Performance

Business Segment: Power Sales

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Rest of the World (ROW)

Performance

Geographical Segment: The US

Performance

Geographical Segment: Within India

Performance

R&D Overview

Shilpa Medicare Ltd - Corporate Strategy

Shilpa Medicare Ltd - SWOT Analysis

SWOT Analysis - Overview

Shilpa Medicare Ltd - Strengths

Shilpa Medicare Ltd - Weaknesses

Shilpa Medicare Ltd - Opportunities

Shilpa Medicare Ltd - Threats

Shilpa Medicare Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Shilpa Medicare Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Oct 19, 2023: Shilpa Medicare has launched ORAAL for the first time in India

Sep 01, 2023: Shilpa Pharma Lifesciences, Unit II, Raichur, Karnataka has cleared PMDA Japan, GMP inspection

May 22, 2023: Shilpa Medicare : Analytical services division (Unit 7, Nacharam, Hyderabad), US FDA GMP inspection cleared with VAI Classification

Mar 11, 2023: US FDA inspection of Shilpa Medicare Limited, unit VII, analytical services division

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Shilpa Medicare Ltd, Key Facts

Shilpa Medicare Ltd, Key Employees

Shilpa Medicare Ltd, Key Employee Biographies

Shilpa Medicare Ltd, Major Products and Services

Shilpa Medicare Ltd, History

Shilpa Medicare Ltd, Subsidiaries

Shilpa Medicare Ltd, Affiliate

Shilpa Medicare Ltd, Joint Venture

Shilpa Medicare Ltd, Key Competitors

Shilpa Medicare Ltd, Ratios based on current share price

Shilpa Medicare Ltd, Annual Ratios

Shilpa Medicare Ltd, Annual Ratios (Cont…1)

Shilpa Medicare Ltd, Annual Ratios (Cont…2)

Shilpa Medicare Ltd, Interim Ratios

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Shilpa Medicare Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Shilpa Medicare Ltd, Performance Chart (2020 – 2024)

Shilpa Medicare Ltd, Ratio Charts

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Shilpa Medicare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports